Lymph Node Dissection for Small Renal Masses

Michael L. Blute, Mohit Gupta, Paul L. Crispen

Research output: Contribution to journalReview articlepeer-review

Abstract

Because the majority of small renal masses (SRMs; <4 cm) demonstrate low metastatic potential and can be effectively treated with radical or partial nephrectomy, the role of lymph node dissection (LND) at the time of surgery is unclear. A randomized trial demonstrated no survival benefit of LND in clinically localized renal cell carcinoma. Thus, LND is not recommended routinely for SRMs. For patients with high-risk features or radiographic evidence of lymphadenopathy, however, LND may improve local staging and potentially provide a survival benefit. If performed, a LND template should be based on the known lymphatic drainage of the kidneys.

Original languageEnglish (US)
Pages (from-to)269-274
Number of pages6
JournalUrologic Clinics of North America
Volume44
Issue number2
DOIs
StatePublished - May 1 2017
Externally publishedYes

Keywords

  • Lymph node dissection (LND)
  • Renal cell carcinoma (RCC)
  • Small renal mass (SRM)

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Lymph Node Dissection for Small Renal Masses'. Together they form a unique fingerprint.

Cite this